An interventional study of Motivational interviewing in Patients (>=60 Years Old) Suffering From Mild-moderate Stroke (Ischemic or Hemorrhagic, Stroke Severity Assessed by NIHSS <16 Points), sponsored by Parc Sanitari Pere Virgili. Status unknown at 6 sites in 2 countries. Open to participants aged 60 Years to 110 Years. Per ClinicalTrials.gov, last updated 2021-03-10.
Sponsored by Parc Sanitari Pere Virgili · Not applicable, Interventional, and Prevention
Background: Rehabilitation pathways are crucial to reduce stroke-related disability. Motivational Interviewing (MI), a centred-person intervention aimed to empower and motivate the patient, could be a resource to improve rehabilitation and its outcomes for older stroke survivors.
Objective: The IMAGINE project aims to assess the impact of MI associated to standard geriatric rehabilitation, on 30 days functional improvement measured by the Functional Independence Measure (FIM), compared to standard geriatric rehabilitation alone, in patients admitted to geriatric rehabilitation after a stroke. Secondary objectives will be to assess the impact on physical activity and performance, self-efficacy, sense of coherence, safety, cost-utility and participants' experience, plus functional status at 3 months.
Methods: Multicenter randomized clinical trial in three geriatric rehabilitation departments. Older adults after mild-moderate stroke without previous dementia, post-stroke severe cognitive impairment or delirium at admission, severe previous disability, aphasia or terminal conditions will be randomized into the control or the intervention group (136 per group, total N = 272). The control group will receive written information about the benefits of exercising, besides standard rehabilitation. The intervention group, in addition, will receive 4 sessions of MI by trained nurses. A shared tailored plan based on patients' goals, needs, preferences and capabilities will be agreed. Besides the FIM, in-hospital physical activity will be measured through accelerometers (activPAL) and secondary outcomes using internationally validated scales. As a complex intervention, a process evaluation and cost-utility assessments will be performed too.
Results: Final results are expected by end of 2020. Implications: This project aims to achieve impacts on functional status, disability and physical performance and behavioral (increasing physical activity) and psychological implications (on general self-efficacy and sense of coherence) through a non-pharmacological and likely accessible, acceptable and scalable intervention. Efficiency and value, based on costs/quality adjusted life years, will be assessed. Moreover, a reduction in post-stroke disability would have social benefits also for families and would reduce health and social care costs. In brief, advances will be in terms of a better rehabilitation process.
IMAGINE project aims to investigate the effect of adding an adapted MI approach to the usual geriatric rehabilitation to motivate and empower stroke patients to participate in their own rehabilitation plan and thus, to increase their physical activity and engagement in self-care and other activities. The main aim is to finally improve patients' physical and global function and, in turn, to reduce dependency. As mentioned, there is evidence-base around MI in rehabilitation, which covers functional, clinical and efficiency aspects. It is expected that IMAGINE project will add a relevant contribution for the implementation of this intervention in older adults with post-stroke residual disability and dependency needing rehabilitation. Accordingly, this study should inform practice and policy on how to move forward towards shared decision making and shared responsibilities in a vulnerable population such as older adults with a recent stroke.
545 studies on the registry are indexed under Ischemia; 72 are open to participants now.
This study's planned enrollment of 272 is above the median of 74 across 356 interventional studies indexed under Ischemia.
Browse Ischemia studies →Parc Sanitari Pere Virgili is the lead sponsor of 9 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Standard geriatric rehabilitation combined with 4 MI sessions (within 72 hours from admission, within 6 days, at 1 week from the second session and pre-discharge, respectively). MI will be delivered by nurses trained through a certified MI course and additional group coaching sessions will be offered them throughout the study. Quality control of the MI sessions will be carried out using Motivational Interviewing Treatment Integrity (MITI) Code 3.1.1 through random video recording.
Behavioral: Motivational interviewing
Routine geriatric rehabilitation will include a multidisciplinary and individualized treatment plan based on comprehensive geriatric and specific rehabilitation assessments. As a specific control intervention, within 72 hours from admission a nurse without training in MI will handle the patient written information about generic benefits of exercising.
MI sessions' goals will to obtain patients' collaboration, creating a shared tailored approach to complement the individual geriatric rehabilitation plan, and reinforcing engagement and adherence at 3 months. All 20-minutes sessions will follow the logical sequence of MI by Rollnick and Millner (engaging, focusing, evoking and planning) in a semi-structured format to ensure homogeneity. Content will include: 1) Creating engagement with patients by exploring their preferences, values, goals, and their knowledge and expectations about rehabilitation and recovery, 2) enhancing motivation by evoking patients' strengths and abilities, 3) follow-up and reinforcement, and 4) adapting the plan to the improved abilities and to home setting after discharge.
Change in Functional Independence Measure (FIM).
The FIM is used to track functional evolution during in-hospital rehabilitation process. FIM is comprised of 18 items, grouped into 2 subscales: 1) motor and 2) cognition. The motor subscale includes: Eating, grooming, bathing, dressing (upper body), dressing (lower body), toileting, bladder management, bowel management, transfers (bed/chair/wheelchair), transfers (toilet), transfers (bath/shower), walk/wheelchair, stairs. The cognition subscale includes: Comprehension, expression, social interaction, problem solving, memory. The total score for the FIM instrument (the sum of the motor and cognition subscale scores) will be a value between 18 and 126. The higher the score, the more independent the patient is in performing the task associated with that item.
Time frame: At admission (within 72 hours), 30 days, and at 3 months follow-up.
Modified-Rankin Scale (mRS)
The Modified Rankin Scale (mRS) assesses disability in post-stroke patients and it can be used to track functional evolution over time. A score of 0 is "no disability", 5 is "disability requiring constant care for all needs" and 6 is "death".
Time frame: At admission (within 72 hours; recall period, previous to event), and at 3 months follow-up.
The Canadian Performance Oriented Measure (COPM).
The COPM is a semi-structure interview that enables patient to identify problems and priorities in the three areas of occupational performance: self-care, productivity, and leisure. Once problems have been identify, patient needs to rate them using a 10-point scale. Then, patient will need to pick up to 5 most important problems to work. Finally, two subscale scores are obtained: performance (COPM-P) and satisfaction with performance (COPM-S).
Time frame: At 30 days from admission, and at 3 months follow-up.
In-hospital physical activity.
This will be measured through accelerometers (ActivPAL) located at the preserved leg, to measure mainly time spent sitting and standing.
Time frame: 7 consecutive in-hospital days after admission, preferably within 10 days before discharge.
Short Physical Performance Battery (SPPB).
Improvement in physical performance will be measured using the SPPB, including balance, strength and gait velocity sub-items.
Time frame: At admission (within 72 hours), 30 days, and at 3 months follow-up.
Number of adverse events registration.
The incidence of diverse adverse events will be registered (yes vs. no; and number of times occuring each incident). Variables collected are: Falls, fractures, cranial traumatism, cardiovascular events (specifically: angina, myocardial infarction, TIA, stroke), aspiration pneumonia/respiratory infections, readmissions to acute hospitals and death. A final composite (total number of adverse events for each patient) will be obtained.
Time frame: At 30 days after admission, and at 3 months follow-up.
Self-perceived pain: 10-point numeric scale
Self-perceived pain will be assessed by means of a 10-point numeric scale (0 = no pain at all, 10 = worst possible pain).
Time frame: At 30 days after admission, and at 3 months follow-up.
General Self-Efficacy scale (GSE).
The GSE is a 10-item tool designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life. This scale is correlated to emotion, optimism and work satisfaction. Negative coefficients are found for depression, stress, health complaints, burnout, and anxiety. The total score is calculated by finding the sum of the all items. For the GSE, the total score ranges between 10 and 40, with a higher score indicating more self-efficacy.
Time frame: At 30 days after admission, and at 3 months follow-up.
Sense of coherence (SOC) questionnaire.
SOC-13 has three components: Comprehensibility, Manageability and Meaningfulness. This scale is rated on a 7-point likert scale, a total score can also be used. The mean alpha of the SOC-13 scale was .82 (range = .74 - .81).
Time frame: At 30 days after admission, and at 3 months follow-up.
Process variables - Length of hospital stay.
Length of stay (total numer of days) for each patient will be measured considering as an endpoint patients' hospital discharge.
Time frame: Through study completion, an average of 40 days.
Process variables - Destination at discharge.
Discharge destination (specifically: home, nursing home, long-term care, acute hospital, death) will be registered for each patient.
Time frame: Through study completion, an average of 40 days.
Process variables - Total time of rehabilitation.
Total time of rehabilitation (total numer of days) will be registered for each patient.
Time frame: Through study completion, an average of 40 days.
Cost-utility measures.
Cost-utility will be measured as the ratio between direct costs during hospitalization (considering costs that include workforce time use, exams, use of other hospital resources, visits) and Quality Adjusted Life Years (QALYs) obtained by means of the EQoL-5D administered before and after the treatment. Cost-utility will be calculated as the incremental ratio €/QALYs in the intervention vs. control group.
Time frame: At admission (within 72 hours), 30 days, and at 3 months follow-up.
Rehabilitation efficiency.
Rehabilitation efficiency scores for each patient will be computed as the improvement in the FIM/length of hospital stay.
Time frame: Through study completion, an average of 40 days.
Participants perceptions and experiences of the intervention.
Qualitative evaluation will be aimed to explore participant's experiences in the frame of the process evaluation of the intervention. Process evaluation will be based on MRC guidance, and will focus on how the context, implementation and impact mechanisms will influence the results. In particular, participants' experiences, their perceived impacts as well as unexpected effects will be explored through in-depth interviews at 30 days and at 3 months on a purposeful sample of participants, selected to maximize variability (by gender, disability levels, socio-economic levels, and social support). In addition, a purposeful sample of caregivers and professionals who performed the intervention will be also interviewed and we will conduct a focus group with reference professionals of the wards.
Time frame: At 30 days of hospitalization, and at 3 months follow-up.
Started Jun 2018 (actual). Primary completion is estimated for Jun 2021, 36 months after the start.
Of 71 non-industry interventional studies with no phase under Ischemia, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 46. This study's planned 36 months is close to that.
Counting every sponsor, half of 82 studies reached it within 33 months; a quarter within 16 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Parc Sanitari Pere Virgili